Wiaczeslaw Smolokowski is 10% Owner at Karyopharm Therapeutics Inc. (KPTI). They have made 5 open-market trades across 2 companies since 2014, most recently 2023-06-26.
CIK 0001591274
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 40% | 60% |
| Avg Move | -21.6% | -5.2% | -17.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRV | SELL | 2023-06-26 | 2023-06-28 | $12.93 | $207 | -10.2% | -6.7% | -33.1% |
| KPTI | SELL | 2018-07-23 | 2018-07-25 | $18.64 | $730K | +2.3% | +5.3% | -29.6% |
| KPTI | SELL | 2016-05-25 | 2016-05-27 | $9.74 | $898K | -6.1% | -30.5% | -29.5% |
| KPTI | SELL | 2014-11-10 | 2014-11-12 | $42.83 | $7.0M | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-09-26 | 2014-09-30 | $42.64 | $8.5M | -46.9% | +3.0% | +3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.